参考文献/References:
[1] DONG L J,HE W,HUO S C,et al.The failure experience of complex total hip arthroplastyin osteopetrosis:case report and literature review[J].International journal of clinical and experimental medicine,2015,8(9):14727-14731.
[2] CHERRY S,AGRAWAL K,FOGELMAN I,et al.Osteopetrosis:radiological& radionuclide imaging[J].Indian Journal of Nuclear Medicine,2015,30(1):55-58.
[3] KASPER D,PLANELLS-CASES R,FUHRMANN J C,et al.Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration[J].The EMBO Journal,2005,24(5):1079-1091.
[4] FUTAI M,SUN-WADA G H,WADA Y,et al.Vacuolar-type ATPase:a proton pump to lysosomal trafficking[J].Physical and Biological Sciences,2019,95(6):261-277.
[5] MATSUMOTO N,DAIDO S,SUN-WADA G H,et al.Diversity of proton pumps in osteoclasts:V-ATPase with a3 and d2 isoforms is a major form in osteoclasts[J].Biochimica et Biophysica Acta,2014,1837(6):744-749.
[6] MATSUMOTO N,SEKIYA M,TOHYAMA K,et al.Essential role of the a3 isoform of V-ATPase in secretory lysosome trafficking via Rab7 recruitment[J].Scientific Reports,2018,8(1):6701.
[7] SOBACCHI C,SCHULZ A,COXON F P,et al.Osteopetrosis:genetics treatment and new insights into osteoclast function[J].Nat Rev Endocrinol,2013,9(9):522-536.
[8] 周绪昌,曹红,邹军,等.SNX10基因突变对常染色体隐性骨质硬化症及其并发症的影响[J].生命科学,2019,31(6):596-601.
[9] 宋玉文,徐晓杰,吕芳,等.CLCN7基因突变致常染色体显性遗传性骨硬化症:1例家系研究[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(4):328-335.
[10] ZHANG X Y,WEI Z Y,HE J,et al.Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type Ⅱ(ADOⅡ)and intermediate autosomal recessive osteopetrosis(ARO)in seven Chinese families[J].Postgraduate Medicine,2017,129(8):934-942.
[11] EKICI M A,CIKLA U,BAUER A,et al.Osteopertrosis and Chiari type imalformation:a rare association[J].J Surg Case Rep,2015,10:rjv084.
[12] XIE L,DING F,JIAO J,et al.Total hip and knee arthroplasty in a patient with osteopetrosis:a case report and review of the literature[J].BMC Musculoskeletal Disorders,2015,16:259-263.
[13] SHARMA S S,SARAVANAN C,SATHYABAMA V,et al.Osteopetrosis of the mandible masqueradingas tubercular osteomyelitis[J].BMJ Case Rep,2013:bcr201200 7487.
[14] 欧明林,薛雯,邹同祥,等.应用全外显子组测序技术筛查罕见石骨症致病基因[J].国际检验医学杂志,2018,39(1):10-13.
[15] ORCHARD P J,FASTH A L,LE RADEMACHER J,et al. Hematopoietic stem cell transplantation for infantile osteopetrosis[J].Blood,2015,126(2):270-276.
[16]KULPIYA A,MAHACHOKLERTWATTANA P,PAKAKASAMA S,et al.Hypercalcemia and altered biochemical bone markers in post-bone marrow transplantation osteopetrosis:a case report and literature review[J].Pediatric Transplantation,2012,16(5):140-145.
[17] PALAGANO E,MENALE C,SOBACCHI C,et al.Genetics of osteopetrosis[J].Curr Osteoporos Rep,2018,16(1):13-25.
[18] IMRANUL A,GRAY A K,ACTON D,et al.Interferon gamma,but not calcitriol improves the osteopetrotic phenotypes in ADO2 mice[J].Journal of Bone and Mineral Research,2015,30(11):2005-2013.
[19] MOSCATELLI I,L?FVALL H,THUDIUM C S,et al.Targeting NSG mice engrafting cells with a clinically applicable lentiviral vector corrects osteoclasts in infantile malignant osteopetrosis[J].Hum Gene Ther,2018,29(8):938-949.
[20] MAURIZI A,CAPULLI M,PATEL R,et al.RNA interference therapy for autosomal dominant osteopetrosis type 2:towards the preclinical development[J].Bone,2018,110:343-354.